26 May 2023

PHARMANUTRA S.P.A.: CETILAR® SIDE BY SIDE WITH FERNANDO ALONSO

08 May 2023

PHARMANUTRA S.P.A.: BOARD OF DIRECTORS APPROVES INTERIM REPORT TO 31 MARCH 2023

12 April 2023

PHARMANUTRA SIGNS THREE NEW AGREEMENTS FOR THE FOREIGN DISTRIBUTION OF SIDERAL® PRODUCTS

17 March 2023

PHARMANUTRA S.P.A: DEPOSITO DOCUMENTAZIONE PER ASSEMBLEA DEGLI AZIONISTI

16 March 2023

PHARMANUTRA: THE BOD APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2022

Sorry, this entry is only available in Italian.:

21 February 2023

PHARMANUTRA THE STRATEGIC GUIDELINES FOR THE NEXT YEARS WERE PRESENTED AT THE INVESTOR’S DAY

08 February 2023

PHARMANUTRA PARTNERS WITH FERRARI TO FACE THE CHALLENGES OF THE NEW LE MANS HYPERCAR 499P

24 January 2023

INTEGRATION OF THE 2023 CORPORATE EVENTS CALENDAR

12 January 2023

PUBLICATION OF THE 2023 CORPORATE EVENTS CALENDAR

04 January 2023

NEW DISTRIBUTION AGREEMENTS IN INDONESIA, KUWAIT AND MEXICO

12 December 2022

NEW COMPANY PHARMANUTRA U.S.A. CORP. ESTABLISHED FOR DISTRIBUTION IN THE UNITED STATES

05 December 2022

PHARMANUTRA S.P.A. COMPLETES AKERN S.R.L. ACQUISITION